ArticleJournal of clinical hypertension (Greenwich, Conn.)2020

Randomized, "head-to-head" studies comparing different SGLT2 inhibitors are definitely needed.

Kazuomi Kario et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.